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Angioplasty of the hand arteries in critical hand ischaemia.
Zolta´n Ruzsa1, Zolta´n Ruzsa1, Karoly Toth2, Zolta´n Jambrik1, Nandor Kovacs2,
György Szabo´3, Levente Molnar1, Ka´lma´n Hüttl1, Béla Merkely1
1Semmelweis University, Budapest, Hungary, 2Ba´cs-Kiskun County Hospital,
Kecskemét, Hungary, 3Semmelweis University of Budapest, Budapest, Hungary
Background: Critical hand ischaemia (CHI) of the upper extremity is rarely encountered.
Axillary, brachial and below-the-elbow (BTE) disease is often asymptomatic due to
highly developed collaterals, but in diffuse- multiple and thrombotic disease CHI can
develop. The aim of this prospective study was to assess the feasibility, safety and
outcomes of percutaneous transluminal angioplasty (PTA) in the treatment of CHI.
Methods: Twenty-one patients (age 72  13 years; six females) were treated with
angioplasty in 2011 (16 pain at rest; 2 non-healing ulcer; 3 gangrene) due to axillary-
brachial and pure BTE artery disease. We examined the procedural and clinical success
and the rate of major adverse events (MAE) and vascular complications.
Results: One patient had Takayasu arteritis and 3 patients had symptomatic radial artery
occlusion after transradial PCI in the investigated population. Six patients (n6, 29%) had
subacute occlusion and 11 patients had chronic disease (n15, 71%). Multilevel (n8,
38%), unilevel dilatations (13, 62%) and in 3 cases parallel dilatations were performed
(n3, 14%). Angioplasty was performed in the axillary (n6), brachial (n12), radial
(n5), ulnar (n8), interosseus (n1) and in palmar arch (n2). Technical success rate
was 95% (20/21). Successful mechanical (Rotarex, n1, 17%) and aspiration thrombec-
tomy (n5, 83%) was performed in subacute cases, before angioplasty (n6, 100%) and
stenting (n3, 50%). In chronic cases angioplasty was performed in all cases (15, 100%)
and additional stenting was necessary in 6 cases (40%). PTA was unsuccessful in one
patient (1/21, 5%). The hand-healing rate in the patients with gangrene and non-healing
ulcer was 100% (5/5), and the relief of the pain was observed in 20 patients (20/21, 95%).
Two patients (n2, 9.5%) underwent secondary procedures due to symptomatic reste-
nosis. The MAE rate was 0% during follow-up. One vascular complication (5%) occurred
in the investigated population (radial artery perforation successfully treated with com-
pression bandage).
Conclusions: Angioplasty of the hand vessels for CHI is a feasible and safe procedure
with acceptable rates of technical success and hand healing.
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Acute Outcomes For A Below The Knee Use Of A Novel Balloon Catheter
First In Man Clinical Study
Dierk Scheinert1
1Park-Krankenhaus Leipzig, Leipzig, Germany
Background: The Chocolate FIM Study will confirm device safety and assess the
occurrence of vascular and procedural complications after treatment with the novel
Chocolate PTA Balloon Catheter.
Methods: Angioplasty for peripheral vascular disease is often associated with acute
complications following inflation and deflation of a standard balloon. Such complications
are commonly considered to be related to vessel trauma and often require bailout stenting.
The Chocolate PTA Balloon Catheter (developed by Quattro Vascular, Singapore/
distributed by TriReme Medical, CA) is a novel balloon catheter with a mounted
constraining structure to allow for uniform inflation and rapid deflation. The attributes of
the constrained balloon are designed for modulated dilatation and creation of small balloon
segments (“pillows”), intended to minimize vessel damage. The first in man use of this novel
device is described here. Acute assessments include: technical success (50% residual
stenosis without flow-limiting dissection), rate of bailout stenting, and occurrence/severity of
dissection and the occurrence of in-hospital major adverse events (MAE- defined as TLR,
death, or major amputation). All treatment angiograms are independently reviewed by a core
lab to confirm vascular outcomes after treatment with the Chocolate Balloon. Clinical and
Duplex Ultrasound follow-up at 1, 6, and 12 months is on-going.
Results: The Chocolate Balloon has been used in the first 22 patients (58% CLI) to treat BTK
target lesions (average length 11cm). The Chocolate device was used successfully in a diverse
range of BTK vessels (AT (48%), PER (14%), Trunk only (14%), Trunk to PER (14%), Trunk
to PT (5%), PT (3%)). Acute results include successful delivery and deployment in all cases.
Technical Success is 100%. Bail-out stenting is 0%. No flow- limiting dissection has been
reported for any Chocolate case. No in-hospital or 30 day MAEs has been reported. 6 Month
MAE and Patency data will be included in presentation.
Conclusions: These initial cases verify that the Chocolate Balloon is safe for use. These
early data also present compelling evidence to suggest that the design of the Chocolate
Balloon is effective in reducing proced.
TCT-184
Subintimal Angioplasty (SIA)or Bypass Surgery(BG) in CLI Patients With
TASC II Type C/D Lesions. Mid to long term Clinical outcome
Sherif Sultan1, Niamh Hynes2
1Western Vascular Institute, Galway, — Please Select —, 2Western Vascular
Institute, Galway, Ireland
Background: Of 1076 patients referred with PVD from 2002 to 2007, 206 SIAs in 190
patients and 128 bypass grafts in 119 patients were enrolled in the study. All patients had
rest pain and/or tissue loss.
Methods: Primary endpoints were survival free from amputation and sustained clinical
improvement. Secondary endpoints were major adverse events (MAE), the binary
restenosis rate, freedom from TLR, and a special quality-adjusted life year (QALY)
endpoint (Q-TWiST) that incorporated both length and quality of life to evaluate
treatments.
Results: At 5 years, clinical improvement was sustained in 82.8% of the SIA group
versus 68.2% of the BG patients (p50.106). Five-year all-cause survival was similar for
SIA (78.6%) and BG (80.1%; p0.734), as was amputation-free survival (SIA 72.9%
versus BG 71.2%;p0.976). Hyperfibrinogenemia (p0.009) and C-reactive protein
(p0.019) had negative effects on survival without amputation. Five-year freedom from
binary restenosis rates were 72.8% for SIA versus 65.3% for BG (p0.700). While the
5-year freedom from TLR rates (SIA 85.9% versus BS 72.1%, p0.262) were not
statistically significant, the risk of MAE (p0.002) and length of hospital stay (p0.0001)
were significantly reduced. Q-TWiST significantly improved (p0.001) and cost-per-
QALY was reduced with SIA. The 5-year risk of re-intervention (p0.05) and mean
number of procedures (p0.078) were similar.
Conclusions: Five-year freedom from MAE was enhanced by 20% in the SIA group,
with substantial cost reduction and better Q-TWiST. SIA is a minimally invasive
technique that expands amputation-free and symptom-free survival. SIA is a paradigm
shift in the management of CLI.
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ASSOCIATION BETWEEN THE ANKLE-BRACHIAL INDEX AND THE
SEVERITY OF CORONARY ARTERY DISEASE
Yong Kyu Park1, Uk Jo1, Seung Mo Kang1, Shin-Eui Yoon1, Hyun Woo Park1,
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Young-Hak Kim1, Cheol Whan Lee1, Seong-Wook Park1, Seung-Jung Park1
1Heart Institute, University of Ulsan College of Medicine, Asan Medical center,
Seoul, Korea, Republic of
Background: Lower ankle-brachial index (ABI) was associated with increasing coro-
nary artery disease (CAD) risk and poor prognosis. But the association between the
severity of CAD and the level of ABI has not been clear. We conducted this study to
evaluate the association between the severity of CAD and the level of ABI.
Methods: We prospectively enrolled 2,531 consecutive patients who admitted for
coronary angiography. All patients underwent ABI during hospitalization period. We
classified as Group I (normal ABI defined as0.9), Group II (mildly low ABI defined as
0.71-0.9), Group III (moderately low ABI defined as 0.41-0.7) and Group IV (severely
low ABI defined as 0.41).,according to ABI values.
Results: The mean age was 62.89.2. The distribution of severity of coronary artery
disease were normal (n314, 12.4%), 1-vessel (n728, 28.8%), 2-vessel (n570,
22.5%) and 3-vessel disease (n919, 36.3%). Among them, Group I (n2,178, 86.1%),
Group II (n156, 6.2%), Group III (n170, 6.7%) and Group IV (n27, 1.1%) were
identified. Multiple linear regression analysis showed that ABI was significantly associ-
ated with the severity of CAD (SE0.130.04, p0.001). The lower ABI group
showed more severe CAD compared with normal ABI group (Table 1.)
Normal
1-vessel
CAD
2-vessel
CAD 3-vessel CAD
n % n % n % n %
Group I 290 13.3 666 30.6 499 22.9 723 33.2
Group II 16 10.3 29 18.6 27 17.3 84 53.8
Group III 8 4.7 29 17.1 39 22.9 94 55.3
Group IV 0 0.0 4 14.8 5 18.5 18 66.7
p0.001
Conclusions: The lower level of ABI was strongly associated with more severe CAD.
The ABI might be a valuable indicator of severity of CAD.
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Relationship between improvement of skin perfusion pressure, clinical
outcomes and wound blush after successful endovascular treatment
Makoto Utsunomiya1, Yoshinori Nagashima2, Masato Nakamura3, Kaoru Sugi1
1Toho University Ohashi Medical Center, Tokyo, Japan, 2Toho University Ohashi
medical center, Tokyo, Japan, 3Toho university, Ohashi Medical Center, Tokyo,
Japan
Background: Several reports have been published of the acceptable patency and limb
salvage rates following infra-popliteal interventions for the treatment of critical limb
ischemia (CLI). However, the optimal angiographic endpoint of endovascular therapy
(EVT) remains unclear. The aim of this study was to assess the relationship between the
appearance of wound blush as an angiographic endpoint, improvement of skin perfusion
pressure (SPP) and clinical outcomes.
Methods: “Wound blush” was defined as contrast opacification of the vessels around the
wound in digital subtraction angiograms obtained immediately after the EVT through the
catheter introduced into the popliteal artery. We analyzed the data of 77 consecutive
patients (93 limbs) with ischemic ulcerations classified as Rutherford category 5 or 6, who
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underwent EVT alone, without bypass surgery. Patients were divided into two groups
depending on whether or not wound blush was obtained in the angiogram obtained
immediately after the procedure, SPP and the ’freedom from amputation’ rate was
compared between the two groups.
Results: Improvement of the SPP measured near the ulcer was observed after the EVT
in both groups; however, the improvement was more pronounced in the WB-positive
group (23.413.6 mmHg vs. 9.511.0 mmHg, P0,001).The overall limb salvage rate
was 81.7%. The limb salvage rate was significantly higher in the wound blush-positive
group than in the wound blush-negative group, and remained so for at least 3 years after
the EVT (96.4% vs. 56.8%, P0.001).
Conclusions: Presence of wound blush after EVT is associated with higher SPP, both of
which are associated with higher rates of limb salvage. Wound blush as an angiographic
endpoint in EVT may be a novel predictor of limb salvage in patients with CLI.
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Factors of Restenosis After Endovascular Treatment for Iliac Artery
Hideyuki Takimura1, Keisuke Hirano2, Yoshimitsu Soga3, Daizo Kawasaki4,
Ryouji Koshida5, Yoshiaki Shintani6, Nobuhiro Suematsu7, Kenji Suzuki8,
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Miyagi, 9Kyoto University, 1, Japan, 10Matsuyama Red-cross Hospital,
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Background: The factors associated with restenosis after endovascular treatment (EVT)
for iliac artery lesions in peripheral arterial disease (PAD) were not established. The aim
of this study was to investigate the predictors of restenosis after EVT for iliac artery.
Methods: The REAL-AI (REtrospective multicenter AnaLysis of primary stenting for
AortoIliac artery disease) registry was performed as a multicenter registry enrolling
consecutive patients undergoing primary stenting for de novo lesion. From January 2005
to December 2009, a total of 2096 patients (2601 lesions, age: 71.37.5years, mean
follow interval 3115 months, claudicant: 82.2%) were enrolled. Univariate and
multivariate analysis were performed to estimate the predictors of restenosis after EVT for
iliac artery.
Results: EVT was performed for 2601 lesions (TransAtlantic Inter-Society Consensus-II
(TASC-II) Type-A: 1201, B: 694, C: 311, D: 395) in PAD patients. The mean lesion
length was 5331mm. Restenosis rate was 14.1% (368 lesions), primary patency was
92.5% at 1 year. The mean term of restenosis from procedure was 810.4548.8 days.
Results of multivariate analysis were shown in the table.
Conclusions: We found stent fracture, low out flow and non-use of aspirin to be
predictors associated with restenosis after EVT for iliac artery.
OR 95% CI P value
Age 1.0 1.005-1.003 0.009
Tall 1.0 1.00-1.04 0.002
Fracture 13.6 1.67-281.28 0.015
Dyslipidemia 1.4 1.10-1.85 0.008
Insulin 1.5 1.04-2.02 0.029
Vessel diameter 1.1 0.97-1.22 0.180
Out flow 1.7 1.28-2.18 0.001
Aspirin 0.6 0.41-0.81 0.002
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Efficacy of the Novel Ultrasonography “Vascular Elastography” Guided
Endovascular Therapy
Hideyuki Takimura1, Toshiya Muramatsu1, Reiko Tsukahara2, Yoshiaki Ito2,
Tsuyoshi Sakai1, Hiroshi Ishimori3, Keisuke Hirano4, Masatsugu Nakano4,
Masahiro Yamawaki1, Tamon Kato5, Norihiro Kobayashi6, Yasunari Sakamoto1,
Takuro Takama6
1Saiseikai Yokohama-city Eastern Hospital, Yokohama, Japan, 2Saiseikai
Yokohama-city Eastern Hospital, Yokohama-city, Kanagawa, 3Saiseikai Yokohama-
city Eastern hospital, Yokohama, Japan, 4Saiseikai Yokohama City Eastern
Hospital, Yokohama, Kanagawa, 5Saiseikai Yokohama-city Eastern Hospital,
Yokohama, Kanagawa, 6Saiseikai Yokohama-city Eastern Hospital, Yokohama,
Kanagawa
Background: The success rate of endovascular therapy (EVT) for chronic total occlusion
(CTO) of femoropopliteal arteries has improved because of devices development and the
introduction of the echo guided EVT from body surface. But now this is still challenging.
Elastography is a new ultrasonographic method that has been examined as a diagnostic
tool for breast lesions. We applied this method to hardness measurement of CTO lesions
by our original method. Our aim was to investigate the usefulness of the novel
ultrasonography (US) “vascular elastography (VE)” for EVT.
Methods: In 516 consecutive cases which underwent EVT between April 2010 and
December 2011, we focused on 56 cases of EVT for CTO of femoropopliteal arteries. We
assessed the CTO lesions by duplex US and “VE” about lesion morphology with our
original methods before procedure. US was performed with 8 MHz linear transducer
(Aprio XG, TOSHIBA, Japan), and off-line analysis of “VE” was performed with
elasto-Q (TOSHIBA, Japan). We originally categorized into five types by original VE
score. Comparing investigation about procedure results was performed between hard
group (H group: VE score 0-2) and soft group (S group: VE score 3-4).
Results: We could assess elastogram of target lesions in all cases (H group: 33 cases vs.
S group: 23 cases). Cases in S group could be penetrated with hydrocoat soft guidewire
(12.1% vs. 65.2%; p0.001). Retrograde approach from popliteal artery was needed in
only H group (39.1% vs. 0%; p0.007). Operation time in H group was longer than S
group (152.963.2min vs. 87.029.8min; p0.001). In 6 cases, CTO site was assessed
soft with thrombus. Therefore we successfully performed thrombectomy and distal
protection preventing for distal embolism. Hard plaque (VE score 1-2) which difficultly
penetrated without calcification by B mode of US could be assessed in 10 cases. In 11
cases with VE score 4, hydrophilic soft guidewire (Cruse®, Asahi Intecc Co. Ltd., Japan)
could pass the lesion easily at the site of soft appearance by VE.
Conclusions: “Vascular Elastography” might be useful when we decide strategies and
selections of device in EVT because we could assess the vascular morphology noninva-
sively before procedure.
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Plaque Excision as a Treatment Option for Popliteal Atherosclerotic Disease:
1-Year Results from the DEFINITIVE LE Study
James McKinsey1, Thomas Zeller2, Lawrence Garcia3
1Columbia/Cornell New York Presbyterian Hospital System, New York, NY,
2Universitaets-Herzzentrum Freiburg-Bad Krozingen, Bad Kronzingen, Germany,
3St. Elizabeth’s Medical Center, Boston, MA
Background: The popliteal artery is often referred to as the no-stent zone due to
concern for stent fracture, kinking or occlusion secondary to the constant torsion,
compression and flexion applied to the vessel. The DEFINITIVE LE study was a global
study that assessed the effectiveness of atherectomy using the SilverHawk® and
TurboHawkTM systems (Covidien/ev3, Plymouth, MN) for peripheral arterial disease
(P.A.D.) in femoropopliteal and tibial-peroneal arteries in both claudicants and critical
limb ischemia (CLI).
Methods: 800 patients with a total of 1023 infrainguinal lesions were enrolled in
DEFINITIVE LE and underwent revascularization with atherectomy. A subset analysis
was performed for all patients with lesions in the popliteal no-stent zone. Follow-up
occurred at pre-discharge, 30 days, 6 months and 1 year. Endpoints were assessed by
independent angiographic and duplex core laboratories and adverse events by a Clinical
Events Committee. The primary endpoint for claudicants was primary patency. Secondary
assessments included Rutherford Clinical Category, ankle-brachial index, the Walking
Impact Questionnaire, EQ-5D and adverse events.
Results: Preliminary results are reported below; final results will be presented at TCT
2012. In total, 158 subjects had 162 target lesions in the popliteal artery. 70.4% (114/162)
of those lesions were in claudicants. The mean lesion length was 5.8 cm and the mean
baseline stenosis was 75.8%. Primary patency (PSVR  2.4) was 80.3% at 1 year.
Demographics, lesion characteristics and outcomes are shown below. The bailout stent
rate was 3.7% for popliteal lesions.
Characteristic/Outcome
Popliteal only
(n158, 162
lesions)
Age (yrs) 72.0  10.9
Female 48.1%
Caucasian 71.5%
History and risk factors
Hypertension 94.9%
Diabetes 52.5%
Renal insufficiency 22.8%
Current or former smoker 33.5%
Mean lesion length (cm) 5.8  3.9
Baseline diameter stenosis 76.2%  18.2%
Post-plaque excision stenosis 25.7%  14.7%
Device success 71.3%
1-year primary patency (PSVR 2.4) (Claudicants) 80.4%
1-year primary patency (PSVR 3.5) (Claudicants) 81.4%
Freedom from amputation (CLI) 100%
Conclusions: These independent core laboratory confirmed results show that atherec-
tomy is highly effective in the treatment of atherosclerotic lesions of the popliteal artery
and can avoid the use of stents in his complex anatomic region.
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